{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:36:49Z","timestamp":1782941809724,"version":"3.54.5"},"reference-count":78,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["High Altitude Medicine &amp; Biology"],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:p>\n                    Luks, Andrew M. and Colin K. Grissom. Return to high altitude after recovery from coronavirus disease 2019.\n                    <jats:italic toggle=\"yes\">High Alt Med Biol<\/jats:italic>\n                    . 22: 119\u2013127, 2021.\u2014With the increasing availability of coronavirus disease 2019 (COVID-19) vaccines and the eventual decline in the burden of the disease, it is anticipated that all forms of tourism, including travel to high altitude, will rebound in the near future. Given the physiologic challenges posed by hypobaric hypoxia at high altitude, it is useful to consider whether high-altitude travel will pose risks to those previously infected with severe acute respiratory syndrome coronavirus 2, particularly those with persistent symptoms after resolution of their infection. Although no studies have specifically examined this question as of yet, available data on the cardiopulmonary sequelae of COVID-19 provide some sense of the problems people may face at high altitude and who warrants evaluation before such endeavors. On average, most individuals who have recovered from COVID-19 have normal or near normal gas exchange, pulmonary function testing, cardiovascular function, and exercise capacity, although a subset of individuals have persistent functional deficits in some or all of these domains when examined up to 5 months after infection. Evaluation is warranted before planned high-altitude travel in individuals with persistent symptoms at least 2 weeks after a positive test or hospital discharge as well as in those who required care in an intensive care unit or suffered from myocarditis or arterial or venous thromboembolism. Depending on the results of this testing, planned high-altitude travel may need to be modified or even deferred pending resolution of the identified abnormalities. As more people travel to high altitude after the pandemic and further studies are conducted, additional data should become available to provide further guidance on these issues.\n                  <\/jats:p>","DOI":"10.1089\/ham.2021.0049","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T09:43:11Z","timestamp":1620812591000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Return to High Altitude After Recovery from Coronavirus Disease 2019"],"prefix":"10.1177","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-7464","authenticated-orcid":false,"given":"Andrew M.","family":"Luks","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, University of Washington, Seattle, Washington, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin K.","family":"Grissom","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center and the University of Utah, Salt Lake City, Utah, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00532-5"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960060612"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216086"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048335"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMcp1214870","article-title":"Clinical practice: Acute high-altitude illnesses","volume":"368","author":"Bartsch P","year":"2013","unstructured":"Bartsch P, , and Swenson ER. (2013). Clinical practice: Acute high-altitude illnesses. N Engl J Med, 368:2294\u20132302.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36142"},{"key":"e_1_3_4_8_1","first-page":"5253","article-title":"[Exercise capacity after mechanical ventilation because of COVID-19: Cardiopulmonary exercise tests in clinical rehabilitation]","volume":"164","author":"Blokland IJ","year":"2020","unstructured":"Blokland IJ, , Ilbrink S, , Houdijk H, , Dijkstra JW, , van Bennekom CAM, , Fickert R, , de Lijster R, , and Groot FP. (2020). [Exercise capacity after mechanical ventilation because of COVID-19: Cardiopulmonary exercise tests in clinical rehabilitation]. Ned Tijdschr Geneeskd, 164:D5253.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2012.1044"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603"},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.echo.2020.10.009","article-title":"Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery","volume":"34","author":"Catena C","year":"2021","unstructured":"Catena C, , Colussi G, , Bulfone L, , Da Porto A, , Tascini C, , and Sechi LA. (2021). Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery. J Am Soc Echocardiogr, 34:193\u2013195.","journal-title":"J Am Soc Echocardiogr"},{"key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.7326\/M20-5661","article-title":"Sixty-day outcomes among patients hospitalized with COVID-19","volume":"174","author":"Chopra V","year":"2020","unstructured":"Chopra V, , Flanders SA, , O'Malley M, , Malani AN, , and Prescott HC. (2020). Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med, 174:576\u2013578.","journal-title":"Ann Intern Med"},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1183\/09031936.00.15463500","article-title":"Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438m (8,000 ft) altitude","volume":"15","author":"Christensen CC","year":"2000","unstructured":"Christensen CC, , Ryg M, , Refvem OK, , and Skjonsberg OH. (2000). Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438m (8,000 ft) altitude. Eur Respir J, 15:635\u2013639.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052573"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106197"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00070404"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2015.0058"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.09.001"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.443"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1152\/jappl.1990.69.4.1236","article-title":"Ventilatory responses to chemoreceptor stimulation after hypoxic acclimatization in awake goats","volume":"69","author":"Engwall MJ","year":"1990","unstructured":"Engwall MJ, , and Bisgard GE. (1990). Ventilatory responses to chemoreceptor stimulation after hypoxic acclimatization in awake goats. J Appl Physiol (1985), 69:1236\u20131243.","journal-title":"J Appl Physiol (1985)"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.072"},{"key":"e_1_3_4_22_1","article-title":"Lung function deficits and symptom burden in survivors of COVID-19 requiring mechanical ventilation","author":"Finney LJ","year":"2021","unstructured":"Finney LJ, , Doughty R, , Lovage S, , Spurr L, , Mehta B, , Kemp SV, , Chua F, , Price LC, , Singh S, , and Man WD. (2021). Lung function deficits and symptom burden in survivors of COVID-19 requiring mechanical ventilation. Ann Am Thorac Soc [Epub ahead of print]; DOI: 10.1513\/AnnalsATS.202102-099RL.","journal-title":"Ann Am Thorac Soc"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2147\/COPD.S173039","article-title":"Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: Randomized trial","volume":"13","author":"Furian M","year":"2018","unstructured":"Furian M, , Flueck D, , Latshang TD, , Scheiwiller PM, , Segitz SD, , Mueller-Mottet S, , Murer C, , Steiner A, , Ulrich S, , Rothe T, , Kohler M, , and Bloch KE. (2018a). Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: Randomized trial. Int J Chron Obstruct Pulmon Dis, 13:3529\u20133538.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.chest.2018.06.006","article-title":"Efficacy of dexamethasone in preventing acute mountain sickness in COPD patients. Randomized trial","volume":"154","author":"Furian M","year":"2018","unstructured":"Furian M, , Lichtblau M, , Aeschbacher SS, , Estebesova B, , Emilov B, , Sheraliev U, , Marazhapov NH, , Mademilov M, , Osmonov B, , Bisang M, , Ulrich S, , Latshang TD, , Ulrich S, , Sooronbaev TM, , and Bloch KE. (2018b). Efficacy of dexamethasone in preventing acute mountain sickness in COPD patients. Randomized trial. Chest, 154:788\u2013797.","journal-title":"Chest"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00633-6"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"2003690","DOI":"10.1183\/13993003.03690-2020","article-title":"Pulmonary function and radiological features four months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study","volume":"57","author":"Guler SA","year":"2021","unstructured":"Guler SA, , Ebner L, , Beigelman C, , Bridevaux PO, , Brutsche M, , Clarenbach C, , Garzoni C, , Geiser TK, , Lenoir A, , Mancinetti M, , Naccini B, , Ott SR, , Piquilloud L, , Prella M, , Que YA, , Soccal PM, , von Garnier C, , and Funke-Chambour M. (2021). Pulmonary function and radiological features four months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J, 57:2003690.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198005083021907"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022450"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-8"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.05.004"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"0243882","DOI":"10.1371\/journal.pone.0243882","article-title":"Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection","volume":"15","author":"Jacobs LG","year":"2020","unstructured":"Jacobs LG, , Gourna Paleoudis E, , Lesky-Di Bari D, , Nyirenda T, , Friedman T, , Gupta A, , Rasouli L, , Zetkulic M, , Balani B, , Ogedegbe C, , Bawa H, , Berrol L, , Qureshi N, , and Aschner JL. (2020). Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One, 15:e0243882.","journal-title":"PLoS One"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.5890"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/jappl.1966.21.2.609","article-title":"Cardiac output in man in rest and work during and after acclimatization to 3,800m","volume":"21","author":"Klausen K.","year":"1966","unstructured":"Klausen K. (1966). Cardiac output in man in rest and work during and after acclimatization to 3,800m. J Appl Physiol, 21:609\u2013616.","journal-title":"J Appl Physiol"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049252"},{"key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"2003448","DOI":"10.1183\/13993003.03448-2020","article-title":"Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19","volume":"57","author":"Lerum TV","year":"2020","unstructured":"Lerum TV, , Aalokken TM, , Bronstad E, , Aarli B, , Ikdahl E, , Lund KMA, , Durheim MT, , Rodriguez JR, , Meltzer C, , Tonby K, , Stavem K, , Skjonsberg OH, , Ashraf H, , and Einvik G. (2020). Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19. Eur Respir J, 57:2003448.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2009.10306"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2009.1051"},{"key":"e_1_3_4_38_1","first-page":"371","article-title":"Acute mountain sickness. In: Ward, Milledge and West's High Altitude Medicine and Physiology","author":"Luks AM","year":"2021","unstructured":"Luks AM, , Ainslie PN, , Lawley JS, , Roach RC, , and Simonson TS. (2021). Acute mountain sickness. In: Ward, Milledge and West's High Altitude Medicine and Physiology. Taylor & Franciss Group, Boca Raton, FL, 371\u2013402.","journal-title":"Taylor & Franciss Group, Boca Raton, FL,"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wem.2019.04.006"},{"key":"e_1_3_4_40_1","first-page":"29","article-title":"High altitude and preexisting medical conditions. In: Auerbach's Wilderness Medicine. Auerbach PS, ed. Elsevier, Philadelphia, Pennsylvania","author":"Luks AM","year":"2017","unstructured":"Luks AM, , and Hackett PH. (2017). High altitude and preexisting medical conditions. In: Auerbach's Wilderness Medicine. Auerbach PS, ed. Elsevier, Philadelphia, Pennsylvania. pp. 29\u201339.","journal-title":"pp"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2011.0013"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.035"},{"key":"e_1_3_4_43_1","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2021.0565","article-title":"Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening","author":"Martinez MW","year":"2021","unstructured":"Martinez MW, , Tucker AM, , Bloom OJ, , Green G, , DiFiori JP, , Solomon G, , Phelan D, , Kim JH, , Meeuwisse W, , Sills AK, , Rowe D, , Bogoch II, , Smith PT, , Baggish AL, , Putukian M, , and Engel DJ. (2021). Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol [Epub ahead of print]; DOI: 10.1001\/jamacardio.2021.0565.","journal-title":"JAMA Cardiol"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1985.59.2.360"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2021.01.020"},{"key":"e_1_3_4_46_1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2021.01.004","article-title":"Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study","volume":"82","author":"Moreno-Perez O","year":"2021","unstructured":"Moreno-Perez O, , Merino E, , Leon-Ramirez JM, , Andres M, , Ramos JM, , Arenas-Jimenez J, , Asensio S, , Sanchez R, , Ruiz-Torregrosa P, , Galan I, , Scholz A, , Amo A, , Gonzalez-delaAleja P, , Boix V, , Gil J, , and group CAr. (2021). Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect, 82:378\u2013383.","journal-title":"J Infect"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2010.03.004"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.110.1.286"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z"},{"key":"e_1_3_4_50_1","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1093\/eurheartj\/ehu275","article-title":"Changes in 24h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial","volume":"35","author":"Parati G","year":"2014","unstructured":"Parati G, , Bilo G, , Faini A, , Bilo B, , Revera M, , Giuliano A, , Lombardi C, , Caldara G, , Gregorini F, , Styczkiewicz K, , Zambon A, , Piperno A, , Modesti PA, , Agostoni P, , and Mancia G. (2014). Changes in 24h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial. Eur Heart J, 35:3113\u20133122.","journal-title":"Eur Heart J"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007938"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.2136"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1964.19.3.431"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.3557"},{"key":"e_1_3_4_55_1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03677-2020","article-title":"Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at three-month follow-up","author":"Qin W","year":"2021","unstructured":"Qin W, , Chen S, , Zhang Y, , Dong F, , Zhang Z, , Hu B, , Zhu Z, , Li F, , Wang X, , Wang Y, , Zhen K, , Wang J, , Wan Y, , Li H, , Elalamy I, , Li C, , Zhai Z, , and Wang C. (2021). Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at three-month follow-up. Eur Respir J [Epub ahead of print]; DOI: 10.1183\/13993003.03677-2020.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_56_1","first-page":"116","article-title":"Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection","volume":"6","author":"Rajpal S","year":"2021","unstructured":"Rajpal S, , Tong MS, , Borchers J, , Zareba KM, , Obarski TP, , Simonetti OP, , and Daniels CJ. (2021). Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol, 6:116\u2013118.","journal-title":"JAMA Cardiol"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100683"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1987.63.2.531"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.75.2.314"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008086"},{"key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/jappl.1992.73.1.101","article-title":"Augmented hypoxic ventilatory response in men at altitude","volume":"73","author":"Sato M","year":"1992","unstructured":"Sato M, , Severinghaus JW, , Powell FL, , Xu FD, , and Spellman MJJr. (1992). Augmented hypoxic ventilatory response in men at altitude. J Appl Physiol (1985), 73:101\u2013107.","journal-title":"J Appl Physiol (1985)"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa448"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.022210"},{"key":"e_1_3_4_64_1","article-title":"Short-term cardiac outcome in survivors of COVID-19: A systematic study after hospital discharge","author":"Sechi LA","year":"2021","unstructured":"Sechi LA, , Colussi G, , Bulfone L, , Brosolo G, , Da Porto A, , Peghin M, , Patruno V, , Tascini C, , and Catena C. (2021). Short-term cardiac outcome in survivors of COVID-19: A systematic study after hospital discharge. Clin Res Cardiol [Epub ahead of print]; DOI: 10.1007\/s00392-020-01800-z.","journal-title":"Clin Res Cardiol"},{"key":"e_1_3_4_65_1","doi-asserted-by":"crossref","first-page":"00094","DOI":"10.1002\/phy2.94","article-title":"Hypovolemia explains the reduced stroke volume at altitude","volume":"1","author":"Siebenmann C","year":"2013","unstructured":"Siebenmann C, , Hug M, , Keiser S, , Muller A, , van Lieshout J, , Rasmussen P, , and Lundby C. (2013). Hypovolemia explains the reduced stroke volume at altitude. Physiol Rep, 1:e00094.","journal-title":"Physiol Rep"},{"key":"e_1_3_4_66_1","doi-asserted-by":"crossref","first-page":"2003481","DOI":"10.1183\/13993003.03481-2020","article-title":"Cardiopulmonary recovery after COVID-19\u2014An observational prospective multi-center trial","volume":"57","author":"Sonnweber T","year":"2020","unstructured":"Sonnweber T, , Sahanic S, , Pizzini A, , Luger A, , Schwabl C, , Sonnweber B, , Kurz K, , Koppelstatter S, , Haschka D, , Petzer V, , Boehm A, , Aichner M, , Tymoszuk P, , Lener D, , Theurl M, , Lorsbach-Kohler A, , Tancevski A, , Schapfl A, , Schaber M, , Hilbe R, , Nairz M, , Puchner B, , Huttenberger D, , Tschurtschenthaler C, , Asshoff M, , Peer A, , Hartig F, , Bellmann R, , Joannidis M, , Gollmann-Tepekoylu C, , Holfeld J, , Feuchtner G, , Egger A, , Hoermann G, , Schroll A, , Fritsche G, , Wildner S, , Bellmann-Weiler R, , Kirchmair R, , Helbok R, , Prosch H, , Rieder D, , Trajanoski Z, , Kronenberg F, , Woll E, , Weiss G, , Widmann G, , Loffler-Ragg J, , and Tancevski I. (2020). Cardiopulmonary recovery after COVID-19\u2014An observational prospective multi-center trial. Eur Respir J, 57:2003481.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_67_1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1113\/JP275278","article-title":"The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800m","volume":"597","author":"Stembridge M","year":"2019","unstructured":"Stembridge M, , Ainslie PN, , Boulet LM, , Anholm J, , Subedi P, , Tymko MM, , Willie CK, , Cooper SM, , and Shave R. (2019). The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800m. J Physiol, 597:1059\u20131072.","journal-title":"J Physiol"},{"key":"e_1_3_4_68_1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/japplphysiol.00903.2004","article-title":"Two temporal components within the human pulmonary vascular response to approximately 2h of isocapnic hypoxia","volume":"98","author":"Talbot NP","year":"2005","unstructured":"Talbot NP, , Balanos GM, , Dorrington KL, , and Robbins PA. (2005). Two temporal components within the human pulmonary vascular response to approximately 2h of isocapnic hypoxia. J Appl Physiol, 98:1125\u20131139.","journal-title":"J Appl Physiol"},{"key":"e_1_3_4_69_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2019.09.034","article-title":"Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns","volume":"301","author":"Torlasco C","year":"2020","unstructured":"Torlasco C, , Bilo G, , Giuliano A, , Soranna D, , Ravaro S, , Oliverio G, , Faini A, , Zambon A, , Lombardi C, , and Parati G. (2020). Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns. Int J Cardiol, 301:173\u2013179.","journal-title":"Int J Cardiol"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020199"},{"key":"e_1_3_4_71_1","article-title":"Comprehensive health assessment three months after recovery from acute COVID-19","author":"van den Borst B","year":"2020","unstructured":"van den Borst B, , Peters JB, , Brink M, , Schoon Y, , Bleeker-Rovers CP, , Schers H, , van Hees HWH, , van Helvoort H, , van den Boogaard M, , van der Hoeven H, , Reijers MH, , Prokop M, , Vercoulen J, , and van den Heuvel M. (2020). Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis [Epub ahead of print]; DOI: 10.1093\/cid\/ciaa1750.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_72_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/rccm.202010-3823LE","article-title":"High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19","volume":"203","author":"van Gassel RJJ","year":"2021","unstructured":"van Gassel RJJ, , Bels JLM, , Raafs A, , van Bussel BCT, , van de Poll MCG, , Simons SO, , van der Meer LWL, , Gietema HA, , Posthuma R, , and van Santen S. (2021). High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19. Am J Respir Crit Care Med, 203:371\u2013374.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_4_73_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/ham.2006.7.39","article-title":"Risk of impaired coagulation in warfarin patients ascending to altitude (>2400m)","volume":"7","author":"Van Patot MC","year":"2006","unstructured":"Van Patot MC, , Hill AE, , Dingmann C, , Gaul L, , Fralick K, , Christians U, , Honigman B, , and Salman MD. (2006). Risk of impaired coagulation in warfarin patients ascending to altitude (>2400m). High Alt Med Biol, 7:39\u201346.","journal-title":"High Alt Med Biol"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1967.22.6.1124"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1987.63.6.2348"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1089\/1527029041352162"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106322"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1983.55.3.688"},{"key":"e_1_3_4_79_1","first-page":"0246732","article-title":"Cardiovascular sequalae in uncomplicated COVID-19 survivors","volume":"16","author":"Zhou M","year":"2021","unstructured":"Zhou M, , Wong CK, , Un KC, , Lau YM, , Lee JC, , Tam FC, , Lau YM, , Lai WH, , Tam AR, , Lam YY, , Pang P, , Tong T, , Tang M, , Tse HF, , Ho D, , Ng MY, , Chan EW, , Wong ICK, , Lau CP, , Hung IF, , and Siu CW. (2021). Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS One, 16:e0246732.","journal-title":"PLoS One"}],"container-title":["High Altitude Medicine &amp; Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/ham.2021.0049","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ham.2021.0049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ham.2021.0049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:24:58Z","timestamp":1777447498000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/ham.2021.0049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6,1]]}},"alternative-id":["10.1089\/ham.2021.0049"],"URL":"https:\/\/doi.org\/10.1089\/ham.2021.0049","relation":{},"ISSN":["1527-0297","1557-8682"],"issn-type":[{"value":"1527-0297","type":"print"},{"value":"1557-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}